Influence of TS (rs34743033) and RUNX1 (rs2014300) gene polymorphisms on survival outcomes of fluorouracil-based chemotherapy in Chinese advanced gastric cancer patients

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• PaolettiXObaKBurzykowskiTGASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) GroupBenefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysisJAMA2010303171729173720442389
   PubMed Web of Science ®Google Scholar
• BangYJKimYWYangHKCLASSIC trial investigatorsAdjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trialLancet2012379981331532122226517
   PubMed Web of Science ®Google Scholar
• DicksonJLCunninghamDSystemic treatment of gastric cancerEur J Gastroenterol Hepatol200416325526315195888
   PubMed Web of Science ®Google Scholar
• SadighiSMohagheghiMAMontazeriASadighiZQuality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)BMC Cancer20066127417147808
   PubMedGoogle Scholar
• LiQFYaoRYLiuKWLvHYJiangTLiangJGenetic polymorphism of GSTP1: prediction of clinical outcome to oxaliplatin/5-FU-based chemotherapy in advanced gastric cancerJ Korean Med Sci201025684685220514304
   PubMed Web of Science ®Google Scholar
• CarrerasCWSantiDVThe catalytic mechanism and structure of thymidylate synthaseAnnu Rev Biochem19956417217627574499
   PubMedGoogle Scholar
• GrazianiSBernauerJSkouloubrisSCatalytic mechanism and structure of viral flavin-dependent thymidylate synthase ThyXJ Biol Chem200628133240482405716707489
   PubMed Web of Science ®Google Scholar
• ToriumiFKubotaTSaikawaYThymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinomaAnticancer Res20042442455246315330198
   PubMed Web of Science ®Google Scholar
• LinDLiHTanWMiaoXWangLGenetic polymorphisms in folate-metabolizing enzymes and risk of gastroesophageal cancers: a potential nutrient-gene interaction in cancer developmentForum Nutr2007606014014517684410
   PubMedGoogle Scholar
• OrinaJNCalcagnoAMWuCPEvaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery databaseMol Cancer Ther2009872057206619584229
   PubMed Web of Science ®Google Scholar
• IacopettaBGrieuFJosephDElsalehHA polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracilBr J Cancer200185682783011556832
   PubMed Web of Science ®Google Scholar
• ArévaloECastañónELópezIThymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexedJ Transl Med20141219824726028
   PubMedGoogle Scholar
• IshidaYKawakamiKTanakaYKanehiraEOmuraKWatanabeGAssociation of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancerAnticancer Res20022252805280912530000
   PubMed Web of Science ®Google Scholar
• RossettiSSacchiNRUNX1: a MicroRNA hub in normal and malignant hematopoiesisInt J Mol Sci20131411566158823344057
   PubMed Web of Science ®Google Scholar
• ItoYBaeSCChuangLSThe RUNX family: developmental regulators in cancerNat Rev Cancer2015152819525592647
   PubMed Web of Science ®Google Scholar
• UsuiTAoyagiKSaekiNExpression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cellsInt J Oncol200629477978416964375
   PubMed Web of Science ®Google Scholar
• ByeHPrescottNJLewisCMDistinct genetic association at the PLCE1 locus with oesophageal squamous cell carcinoma in the South African populationCarcinogenesis201233112155216122865593
   PubMed Web of Science ®Google Scholar
• YuanZYuanHMaHGenetic variants at 10q23 are associated with risk of head and neck cancer in a Chinese populationOral Oncol201349433233523151416
   PubMed Web of Science ®Google Scholar
• IacovelliRPietrantonioFMaggiCde BraudFDi BartolomeoMCombination or single-agent chemotherapy as adjuvant treatment of gastric cancer: a systematic review and meta-analysis of published trialsCrit Rev Oncol Hematol2016989582242826481953
   PubMedGoogle Scholar
• Martinez-BalibreaEManzanoJLMartinez-CardusACombined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecanOncol Rep200717363764517273745
   PubMed Web of Science ®Google Scholar
• PullarkatSTStoehlmacherJGhaderiVThymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapyPharmacogenomics J200111657011913730
   PubMedGoogle Scholar
• OttKVogelsangHMartonNThe thymidylate synthase tandem repeat promoter polymorphism: a predictor for tumor-related survival in neoadjuvant treated locally advanced gastric cancerInt J Cancer2006119122885289416929515
   PubMed Web of Science ®Google Scholar
• JakobsenANielsenJNGyldenkerneNLindebergJThymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivityJ Clin Oncol20052371365136915735113
   PubMed Web of Science ®Google Scholar
• KawakamiKSalongaDParkJMDifferent lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expressionClin Cancer Res20017124096410111751507
   PubMed Web of Science ®Google Scholar
• DasariSTchounwouPBCisplatin in cancer therapy: molecular mechanisms of actionEur J Pharmacol201474036437825058905
   PubMed Web of Science ®Google Scholar
• ShenDWPouliotLMHallMDGottesmanMMCisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changesPharmacol Rev201264370672122659329
   PubMed Web of Science ®Google Scholar
• GalluzziLSenovillaLVitaleIMolecular mechanisms of cisplatin resistanceOncogene201231151869188321892204
   PubMed Web of Science ®Google Scholar
• VenkatramanMAntoRJNairAVargheseMKarunagaranDBiological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosisMol Carcinog2005441515916044419
   PubMed Web of Science ®Google Scholar
• ZhuKChenLHanXWangJWangJShort hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cellsOncol Rep20122741027103422245869
   PubMed Web of Science ®Google Scholar
• BaiTTanakaTYukawaKUmesakiNA novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2′-deoxycytidine and trichostatin in cisplatin-resistant cervical squamous cancer cellsInt J Oncol200628249750816391806
   PubMed Web of Science ®Google Scholar
• HuangSChenMShenYInhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cellsCancer Lett2012315219820522104727
   PubMed Web of Science ®Google Scholar
• XuNShenCLuoYUpregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cellBiochem Biophys Res Commun2012425246847222846564
   PubMed Web of Science ®Google Scholar
• BiroccioABenassiBFiorentinoFZupiGGlutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agentsNeoplasia20046319520615153331
   PubMed Web of Science ®Google Scholar
• BlythKCameronERNeilJCThe RUNX genes: gain or loss of function in cancerNat Rev Cancer20055537638715864279
   PubMed Web of Science ®Google Scholar
• SlatteryMLLundgreenAHerrickJSCaanBJPotterJDWolffRKAssociations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and risk of colon and rectal cancer: additional support for a TGF-β-signaling pathwayCarcinogenesis201132331832621088106
   PubMed Web of Science ®Google Scholar
• KadotaMYangHHGomezBDelineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell linesPLoS One201052e920120169162
   PubMed Web of Science ®Google Scholar
• SakakuraCHagiwaraAMiyagawaKFrequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancerInt J Cancer2005113222122815386419
   PubMed Web of Science ®Google Scholar
• ChoiAIllendulaAPulikkanJARUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemiaBlood2017130151722173328790107
   PubMed Web of Science ®Google Scholar
• FijnemanRJAndersonRARichardsERunx1 is a tumor suppressor gene in the mouse gastrointestinal tractCancer Sci2012103359359922171576
   PubMed Web of Science ®Google Scholar
• AJCC 8th edition of the American Joint Commission on Cancer Staging Manual Available from: https://cancerstaging.org/references-tools/deskreferences/Pages/default.aspxAccessed May 22, 2018
   Google Scholar